TMO vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Thermo Fisher Scientific Inc. and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
VS
Tesla, Inc. · Consumer Cyclical
$387.51
-47.6% upside to fair value
Grade D
QuantHub Verdict
TMO has more upside to fair value
(+10.1%).
TMO trades at a lower forward P/E
(25.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TMO |
TSLA |
| Current Price |
$462.60 |
$387.51 |
| Fair Value Estimate |
$509.20 |
$203.09 |
| Upside to Fair Value |
+10.1%
|
-47.6%
|
| Market Cap |
$171.9B |
$1,454.1B |
| Forward P/E |
25.1x
|
330.0x
|
| EV / EBITDA |
19.0x
|
122.9x
|
| Price / Sales |
3.8x
|
15.3x
|
| Price / FCF |
25.5x
|
233.8x
|
| Revenue Growth YoY |
+6.2%
|
-3.1%
|
| Gross Margin |
39.4%
|
18.0%
|
| Operating Margin |
17.8%
|
4.6%
|
| Return on Equity |
13.3%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.92%
|
0.43%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Tesla, Inc. is a leading global manufacturer of electric vehicles, energy storage, and solar products, led by CEO Elon Musk since 2008. The company has a mixed business quality profile with a strong brand and innovation leadership but faces significant challenges including declining automotive revenue, which fell nearly 10% year-over-year in 2025, and a 3.1% revenue decline in the most recent qua…
Accumulation Zones
| Metric |
TMO |
TSLA |
| Zone Low |
$381.90 |
$152.32 |
| Zone High |
$432.82 |
$172.63 |
| In Buy Zone? |
No
|
No
|